Viral infections remain a major global health threat, responsible for seasonal outbreaks, chronic diseases, and emerging pandemics. Despite advances in virology, there is still a lack of effective antiviral therapies for many viral pathogens, and resistance to existing antivirals is an increasing concern. The COVID-19 pandemic also highlighted the need for rapid, reliable, and translational preclinical models to accelerate drug and vaccine development.